RB homepage

Siemens Healthineers

The Munich, Germany-based company is doing so by transferring 30% of total shares in Siemens Healthineers over to the parent company’s stockholders. 

quality

Its latest update covers scenarios such as abdominal or chest pain in a pediatric patient, chronic pancreatis, and imaging after a liver transplant. 

A new research paper details the path to approval for nearly 1,000 AI/ML algorithms, highlighting significant gaps in testing.

warning safety alert recall healthcare issue

Health officials launched a review of over 21,000 imaging exams after determining that numerous patients had pertinent findings fly under the radar for months. 

A low-dose CT coronary calcium scoring exam showing areas of calcified plaque and bone in pink.

Calcium in the coronary arteries is a known cardiac risk factor. However, new data suggest it may actually tell us more about a person's overall health than researchers previously believed. 

stroke brain dementia alzheimer's puzzle mental health

Although the drug can slow the progression of cognitive decline, it may have little impact on damage already done by AD prior to treatment.

Innovation at work

Six years ago, two radiologists with dissimilar backgrounds and divergent clinical interests put their heads together and launched a new practice. One physician was an academic subspecialized in musculoskeletal reads. The other, a private practitioner, concentrated on oncologic imaging. That’s how Transparent Imaging was born, powered by Konica Minolta. 

Sponsored by Konica Minolta

In a private dining room in Miami, something unusual is happening. Leaders from competing imaging centers are openly discussing their best practices—even sharing vendor recommendations and operational strategies that have doubled their volumes while cutting costs in half.

In cooperation with AbbaDox

Around the web

A growing number of private insurers are now covering these advanced technologies. Roosha Parikh, MD, told Cardiovascular Business that the hard work of SCCT and other groups has helped make this happen. 

Customers are urged to stop using these devices right away.

Researchers used AI-enabled software developed by Cleerly to evaluate the CCTA results of more than 6,000 patients. The software was consistently effective, identifying patients who may face an increased risk of poor outcomes.